<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">


CIPN Models.

Evaluating the neuroprotective effects of test items following chemotherapy treatment.


Register for access

Chemotherapy treatments frequently result in painful neuropathies and neurotoxicity. Chemotherapy-induced neuropathy tends to progress during treatment and generally resides once treatment stops. It is estimated, however, that in 30% of cases it may persist up to 6 months after chemotherapy treatment has finished. Symptoms include motor and sensory, can be prolonged and severe, and is difficult to treat. In this webinar, we present in vivo and in vitro models for understanding the underlying mechanism of CIPN and assessing the neuroprotective effects of compounds in development. 


Webinar (15 min)